C-mo Medical Solutions
C-mo Medical Solutions makes C-mo System, a CE-marked wearable cough monitor that measures cough frequency and intensity for clinical trials.
C-mo Medical Solutions makes C-mo System, a CE-marked wearable cough monitor that measures cough frequency and intensity for clinical trials.
c-mo.solutionsCrawled Oct 15, 2026
Instructions for Use Management Platform v1.6 EN (30/01/2026)
C-mo Medical Solutions develops cough-monitoring technology for clinical trials and medical practice. It raised a €4.1 million seed round led by Boehringer Ingelheim Venture Fund to bring the technology to market.
Cough Monitoring Medical Solutions, S.A. sets terms for installing and using the C-mo Medical Platform software associated with a medical device it provides.
The terms set conditions for visitors’ use of https://c-mo.solutions/.
C-mo Medical Solutions receives a CE Mark for its AI-powered cough monitoring solution. The company says the regulatory milestone supports broader adoption of its privacy-preserving technology in clinical research and medical practice.
Apr 2026 · c-mo.solutionsNews article
C-mo Medical Solutions receives CE marking for its AI-powered cough monitoring solution. The C-mo System combines a wearable biosensor, AI-driven cough analysis, and a digital platform.
Apr 2026 · GlobeNewswireNews article
C-mo Medical Solutions extends its seed investment round to €4.8 million, adding Novalis Biotech as a new investor. Novalis joins Boehringer Ingelheim Venture Fund, Portugal Ventures, and High-Tech Gründerfonds in the round.
Jan 2023 · c-mo.solutionsNews article
C-mo Medical Solutions closes a €4.1 million seed investment round led by Boehringer Ingelheim Venture Fund. Portugal Ventures and High-Tech Gründerfonds also participate in the financing, which the company says aims to transform cough monitoring.
Sep 2022 · c-mo.solutionsNews article